Stoneridge Inc (SRI)
Official siteCONSUMER CYCLICAL • AUTO PARTS • NYSE
Market Cap: $142.48M
Last updated: Nov 17, 2026 at 4:10 PM ET
Stoneridge Inc (SRI) Statistics
Stoneridge (SRI) has a market cap of $142.48M and an enterprise value of $222.72M. It kept -18.92% of revenue as net income over the last 12 months. Its net debt of $80.25M equals 56.32% of its market cap.
Total Valuation
Enterprise value is 56.32% above the market cap, as debt exceeds cash.
| Market Cap | $142.48M |
|---|---|
| Enterprise Value | $222.72M |
| Latest price (Nov 17, 2026) | $4.99 |
Key Dates
The next earnings report is expected on Mar 9, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 9, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.2x and 1.1x. Its year-end P/S ranged from 0.2x to 1.3x from 2016 to 2025.
| P/S Ratio | 0.2x |
|---|---|
| Forward P/S | 0.2x |
| P/B Ratio | 1.1x |
| P/TBV Ratio | 2.5x |
| P/OCF Ratio | 10.3x |
Price Statistics
The stock is down 12.76% over 52 weeks and trades 19.52% below its 50-day average.
| Beta (1Y) | 2.37 |
|---|---|
| 52-Week Change | -12.76% |
| 1-Month Change | -13.07% |
| 3-Month Change | -31.46% |
| 6-Month Change | -25.63% |
| 5-Year Change | -70.07% |
| 10-Year Change | -61.67% |
| Total Return (1Y) | -12.76% |
| Total Return (3Y CAGR) | -33.01% |
| Total Return (5Y CAGR) | -26.11% |
| Return vs SPY (1Y) | -21.00% |
| Max Drawdown (1Y) | -48.53% |
| Max Drawdown (3Y) | -81.71% |
| Sharpe Ratio (1Y) | -0.17 |
| Correlation with SPY (1Y) | 0.55 |
| 50-Day Average | $6.20 |
| 200-Day Average | $6.84 |
| 52-Week Range | $4.60 to $9.71 |
| RSI (14 Days) | 33.5 |
| Average Volume (20 Days) | 216.74K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.96x current liabilities, and total debt is 1.16x shareholder equity.
| Current Ratio | 0.96x |
|---|---|
| Quick Ratio | 0.62x |
| Debt / Equity | 1.16x |
Returns and Efficiency
Return on invested capital is -22.90% over the last 12 months, against a 5-year average of -3.30%.
| Return on Equity (ROE) | -107.02% |
|---|---|
| Return on Assets (ROA) | -26.07% |
| Return on Invested Capital (ROIC) | -22.90% |
| Return on Capital Employed (ROCE) | -42.00% |
| ROE (5Y Average) | -13.92% |
| ROA (5Y Average) | -4.74% |
| ROIC (5Y Average) | -3.30% |
| Asset Turnover | 1.23x |
| Inventory Turnover | 4.96x |
| Receivables Turnover | 5.10x |
| Cash Conversion Cycle | 75 days |
Scores
SRI has an Altman Z-Score of 1.23, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.23 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $703.19M over the last 12 months is up 5.98% from the 12 months before.
| Revenue | $703.19M |
|---|---|
| Revenue Growth (YoY) | +5.98% |
| Gross Profit | $116.44M |
| Operating Income | -$63.45M |
| Pretax Income | -$72.68M |
| Net Income | -$133.01M |
| EBITDA | -$34.60M |
| EBIT | -$61.37M |
| Reported EPS (TTM) | -$3.84 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 24.36% of the $510.16M in total assets.
| Cash and Equivalents | $63.45M |
|---|---|
| Total Debt | $143.69M |
| Net Debt | $80.25M |
| Net Debt Per Share | $2.83 |
| Working Capital | -$13.63M |
| Shareholder Equity | $124.29M |
| Book Value Per Share | $4.38 |
| Tangible Book Value | $57.23M |
| Tangible Book Per Share | $2.02 |
| Total Assets | $510.16M |
| Total Liabilities | $385.87M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $16.07M of capital spending, operating cash flow left -$2.20M of free cash flow.
| Operating Cash Flow | $13.87M |
|---|---|
| Capital Expenditures | $16.07M |
| Free Cash Flow | -$2.20M |
| FCF Per Share | -$0.08 |
| Depreciation and Amortization | $26.77M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -9.02%, against a 5-year average of -0.18%.
| Gross Margin | 16.56% |
|---|---|
| Operating Margin | -9.02% |
| Pretax Margin | -10.34% |
| Net Margin | -18.92% |
| EBITDA Margin | -4.92% |
| EBIT Margin | -8.73% |
| FCF Margin | -0.31% |
| Gross Margin (5Y Average) | 20.49% |
| Operating Margin (5Y Average) | -0.18% |
| Net Margin (5Y Average) | -3.08% |
Growth
Revenue fell 1.45% a year over 3 years.
| Revenue Growth (3Y CAGR) | -1.45% |
|---|---|
| Revenue Growth (5Y CAGR) | +5.85% |
| Book Value Per Share Growth (2Y CAGR) | -21.55% |
| Tangible Book Per Share Growth (2Y CAGR) | -29.14% |
Dividends and Yields
SRI does not pay a dividend. Its free cash flow yield is -1.55%.
| FCF Yield | -1.55% |
|---|---|
| Shareholder Yield | 0.00% |
Peer Position
Against 10 similar companies, SRI has the 8th highest P/S.
P/S RatioPeer median 0.5x
ROICPeer median 2.87%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -2.46%
| P/S Ratio | 0.2x vs 0.5x median |
|---|---|
| ROIC | -22.90% vs 2.87% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +5.98% vs -2.46% median |
Analyst Forecast
Consensus estimates put revenue growth at -8.86% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -8.86% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SRI
What is SRI's market cap?
Stoneridge has a market cap of $142.48M. Its enterprise value, which adds debt and subtracts cash, is $222.72M.
How many shares of SRI are outstanding?
Stoneridge has 28.39M shares outstanding. The count is up 1.90% from a year earlier.
Does SRI pay a dividend?
No. Stoneridge does not pay a dividend.
How much debt does SRI have?
Stoneridge has $143.69M of total debt and $63.45M of cash and equivalents, a net debt position of $80.25M.
SRI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors